Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

Oxatomide

Home DrugsOxatomide

Approved

Small Molecule

Oxatomide

Unknown Manufacturer

Oxatomide is an antihistamine indicated in the treatment and prevention of allergic symptoms.

Generate AI report

Share to Twitter Share to Facebook Share to LinkedIn Share to Reddit

Overview

Oxatomide is an antihistamine indicated in the treatment and prevention of allergic symptoms.

Indications

用于变态反应性鼻炎、结膜炎、枯草热、荨麻疹及食物过敏。

Associated Conditions

6 associated conditions

Asthma, Allergic
Atopic Dermatitis
Chronic Urticaria
Pruritus
Rhinitis
Follicular conjunctivitis

Technical identifiers

Chemical Formula: C₂₇H₃₀N₄O
CAS Number: 60607-34-3
UNII ID: J31IL9Z2EE